Several studies indicate that the outcome of experimental murine cutaneous leishmaniasis caused by Leishmania major (Lm) is determined by immunological events occurring shortly after infection. These events lead to outgrowth of either protective CD4 + T cells in the C57BL/6 mouse, which cures, or exacerbative cells in the BALB/c mouse, which succumbs to disease. Potential factors influencing the outgrowth of protective or exacerbative T cells include antigen-presenting cells (APC), cytokines, and parasite antigens. An in vitro system, in which one could precisely control the factors shaping early events in the T cell response to Lm, would be very useful. To this end, we have examined the in vitro response of naive lymphocytes to Lm promastigotes. The data presented here show that Lm-specific CD4 + T cell receptor c~//~ + T cells can be generated in vitro from spleen and lymph node cell populations of naive mice. Furthermore, they can be obtained from the CD44 l~ (unprimed) population of T lymphocytes, indicating that in vitro priming occurs. The ability to generate these T cells is dependent on the presence of live parasites and is not due to a parasite-derived nonspecific T cell mitogen. Restimulation, as assayed by proliferation, requires APC bearing syngeneic I-A. Optimal restimulation of the in vitro derived T ceils is achieved only when live promastigntes are used. The T cells do not proliferate in response to a frozen-and-thawed lysate of promastigotes, yet they exhibit mild reactivity to lysates prepared from heat-shocked promastigotes. Furthermore, they do not recognize two predominant antigens on the promastigote surface, lipophosphoglycan and gp63. T cells derived in vitro with Lm show crossreactivity with live L. donovani, less crossreactivity with live L. mexicana, and no crossreactivity with live Badllus-Calmette-Guerin or live Brugia malayi microfilariae. Finally, these early T cells, whether derived from healing C57BL/6 or nonhealing BALB/c mice, produce interleukin 2 (IL-2), IL-4, and interferon %
I
n experimental murine cutaneous leishmaniasis caused by Leishmania major (Lm), t it is well known that some strains of mice overcome the infection whereas others succumb to disease (1) . Both cure and noncure responses are mediated by parasite-specific CD4 + T cells that can protect against or exacerbate leishmaniasis (2, 3). There are several ways mice can be immunologically manipulated so as to change the course of disease. Noncuring BALB/c mice can be induced to control Lm infection after infusion of mAbs to IL-4 (4), IL-2 (5), or CD4 (6) . In addition, treatment with anti-/~ 1 Abbreviations used in this paper: HSAg, heat-shock antigen; hsp, heatshock protein; Lra, Leishmania major; LNC, lymph node cells; LPG, lipophosphoglycan; NMS, normal mouse serum; PIV, primary in vitro; SC, spleen cells. serum (7) , sublethal irradiation (8) , administration of cyclosporin A (9), or induction of partial tolerance to Lm Ags (10) results in control of the infection. Conversely, mouse strains that normally cure are unable to resolve infection after infusion of mAb to IFN-3' (11) or anti-# treatment (12) . Of particular interest to the present work is the observation that treatments with mAb to IL-4, IFN-3', and CD4, as well as irradiation and administration of cyclosporin A, must be given during the early phase of infection to be effective (4, 6, 8, 9, 11) . Similarly, treatment with anti-# affects primarily the early phase of infection since/~-suppressed mice exhibit normal disease profiles after adoptive transfer of T cells from infected untreated animals (12) . These observations suggest that immunological events occurring during the initial encounter between Lm and host immune system determine the subsequent outcome of infection.
To study early events in the immune response to Lm, an in vitro model system that mimics the in vivo response would be very useful. Such a system would allow precise control over conditions, i.e., Ag, cytokines, and APC, that may lead to outgrowth of protective or exacerbative T cells.
To this end we have developed a procedure whereby Lmspecific T cells can be generated in vitro from naive mice.
We have shown that these T cells generated by primary in vitro stimulation (PIV T cells) are analogous to those isolated from mice after infection in that they are CD4 + TCR o~//5 +, have strong Lm-spedfic responses, are I-A restricted, and produce IL-2, IL-4, and IFN-%
Materials and Methods
Animals. All mice were purchased as specific pathogen-free animals and were used as young adults. BALB/c mice were obtained from Taconic Farms (Germantown, NY). C57BL/6, C57BL/10, B10.BK/SgSn, B10.AQK, B10.A(SR)/SgSn, DBA/2, SWR/J, CBA/J, and CBA/CaH-T6J mice were obtained from The Jackson Laboratory (Bar Harbor, ME). BALB.B and B10.D2/nSn mice were from Harlan Olac Ltd. (Oxon, UK). Parasites, Antigens, Antibodies, and Cell Lines. Lm was a clone of LV39 and was maintained as previously described (13 In all cases promastigotes from stationary phase cultures were used (15) . Live Mycobacteriura boris BCG Montreal (lot 1012) was obtained from the Trudean Institute (Saranac Lake, NY). Brugia malayi microfilariae were isolated from the peritoneal cavity of infected gerbils as described (16) and were cultured for 10 d at 37~ in DMEM supplemented with 10% FCS, penicillin, streptomycin, and glutamine. Live microfilariae were used and were separated from nonviable parasites by their ability to emerge after embedding in 0.5% low-melt agarose prepared in culture medium.
Lm antigen (LmAg) was prepared by rapid freezing and thawing as described (6) . Lm heat-shock Ag (HSAg) was prepared by culturing parasites for 24 h at 34~ followed by freezing and thawing. Lm metacyclic lipophosphoglycan (LPG) was kindly provided by D. Sacks (National Institutes of Health, Bethesda, MD) and recombinant Lm gp63 was the gift ofR. McMaster (University of British Columbia, Vancouver, Canada).
The mAbs used in this study are listed in Table 1 and were used as cell culture supernatants unless otherwise indicated.
The OVA-specific cell line was produced by immunizing BALB/c mice with OVA at the base of the tail as described (31) . Briefly, 7 d after immunization, draining lymph nodes were removed and cultured for 5 d with OVA. Blast cells were isolated on discontinuous Percoll (Pharmacia, Uppsala, Sweden) density gradients and rested for 10 d. OVA-specific T cells were then isolated by passage over a discontinuous Ficoll gradient as previously described (32) .
Priming of Lm-specific Cells In Vitra Spleens from normal mice were aseptically removed and a single cell suspension was prepared. Cells were washed and resuspended at 5 x 10 + cell/ml in culture medium consisting of DMEM (13) supplemented with 5 x 10 -s M 2-ME and 0.5% normal mouse serum (NMS). Stationary phase Lm promastigotes were then added at 5 x 10S/ml. LmAg was used at a final concentration of 5 x 106 Lm equivalents/ml. 1 ml/well was then plated into 24-well culture plates (Costar, Cambridge, MA). After 3-7 d of incubation, blast cells were isolated on Percoll gradients. Lymph node cells (LNC) were prepared from popliteal, para-aortic, and inguinal lymph nodes and were processed as described for spleen cells (SC). Priming of Thy-l.2+CD44 ~ cells was accomplished as follows. Thy-l.2 + cells from naive BALB/c spleens were prepared using a cocktail of mAbs to B cell surface antigens (RA3-3A1, Jlld) and class II (MK-D6) followed by lysis with Low Tox Rabbit complement (Accurate Chem, & Sci. Corp., Westbury, NY) and removal of dead cells by passage over Ficoll. The remaining cells were ;>95% Thy-l.2 + as assayed by flow cytometry. Cells were then stained with anti-CD44 mAb, 1M7.8.1, and secondary antibody, PE-labeled goat anti-rat IgG preabsorbed with mouse Ig (Southern Biotechnology Associates, Inc., Birmingham, AL). CD44 l~ cells were isolated on an Epics cell sorter (Coulter Electronics Inc., Hialeah, FL) by selecting the lower 50% of the CD44 t~ population. These cells were combined with T cell-depleted splenocytes, <2% Thy-1.24, prepared by complement-mediated lysis using a mAb cocktail of NEI-001, GK1.5, and H35-17.5. The relative proportions of these two populations in the combined mixture was such that the original T cell/non-T cell ratio was preserved: in this case, 2:3. Cells were then cultured with Lra as described. Glasebrook, Eli Lilly, Indianapolis, IN). The effect of a sample supernatant on the proliferation of CTLL or 11.6 was assessed by [3H]thymidine incorporation, and units per milliliter of a particular cytokine in the test supernatant were calculated from a standard curve obtained with either rmlL-2 or rmlL-4 (Genzyme, Cambridge, MA). Specificity was assessed using blocking anti-Ib2 mAb $4B6 or anti-Ib4 mAb 11Bll. IFN-qr activity was detected by capture ELISA performed on 96-well Falcon | 3912 Micro Test IIF M plates (Becton Dickinson Labware, Oxnard, CA) using the rat anti-IFN-3, mAb XMG1.2 as the primary antibody and hamster anti-IFN-'y mAb 5.102.12 as the secondary antibody. XMG1.2 and 5.102.12 were prepared by ammonium sulfate precipitation from cell culture supernatant and ascites, respectively. Binding of the secondary mAb was detected using horseradish peroxidase-conjugated goat anti-hamster Ig preabsorbed to rat Ig (Caltag Labs.), and the ELISA was developed with 3,3',5,5'-tetramethylbenzidine (TMB) peroxidase substrate (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD). Units per milliliter were calculated from a standard curve obtained with rmlFN-3, (a gift of Genentech, South San Francisco, CA).
Results

Naive SC Undergo T Cell Blastogenesis in the Presence of Live
Lra Promastigotes. SC from naive BALB/c mice were coincubated with live Lm promastigotes. The kinetics of the ensuing blastogenic response are shown in Fig. 1 . As early as day 3, a blastogenic response could be observed; small numbers of blast calls, 0.3-1.0% of initial splenocytes plated, could be isolated and restimulated to proliferate in the presence of Lm and fresh irradiated syngeneic SC as APC. By day 7, a potent blastogenic response was clearly discernable. Analysis It was possible that the PIV response to Lm was a characteristic of only certain inbred mouse strains. To test this we examined several strains of mice (Table 2 ) differing in genetic Most experiments were carried out with SC since they were easily obtained in large numbers. However, it was conceivable that the observed effect was unique to the spleen and not obtainable with LNC. Since LNC and not the spleen would be the site of initial exposure to Lm during natural infection, this was an important consideration. Therefore, we cultured naive LNC from C57BL/6 and BALB/c mice with live Lm. A similar blastogenic response was obtained, confirming that this effect was not unique to SC.
We next wanted to ascertain if the responding cells were indeed naive lymphocytes that were primed in vitro or memory cells responding to a crossreactive antigen present in Lm. This was determined by incubating purified CD44 l~ unprimed (38) T cells, prepared from spleen, with Thy-l.2-depleted splenocytes and live Lm. Lm-specific T cell blasts were again obtained, confirming that T cell priming was taking place.
Finally, we wanted to determine if the PIV response required the presence of live Lm or if certain Lm Ag drove this response. We, therefore, incubated naive SC with freezethawed Lm promastigote Ag. No blastogenic response was observed even when the amount of LmAg added was 10 times that present when live parasites were used.
Since it is normally difficult to obtain Ag-specific primary T cell responses in vitro, we wanted to determine if the CD4 § PIV T cells were conventional T cells with respect to their MHC restriction, Ag specificity, and cytokine production.
Conditions Required for Restimulation of PIV T Cells. 7-d PIV T cells were restimulated under various conditions to assess their proliferative requirements. As shown in Fig. 2 A, PIV T cells did not proliferate constitutively, nor did they respond to either Lm or syngeneic SC alone. Only when both APC and Lm were present did the cells proliferate. This was also observed for PIV T cells derived from LNC and CD44 l~ T cells (data not shown).
The data presented above did not eliminate the possibility that PIV T cells were being stimulated by a T cell mitogen produced by living parasites in conjunction with SC. To test this, we incubated an OVA-specific CD4 + T cell line with live Lm and irradiated SC. As can be seen in Fig. 2 B, OVAspecific cells did not proliferate in response to Lm yet responded strongly to OVA. This indicates that the PIV response is not driven by a nonspecific mitogen.
Analysis of PIV T Cell MHC Restriction. We then determined if the MHC restriction pattern of PIV T cells was identical to that observed with conventional CD4 + T cells, i.e., (a) inhibition of proliferation by anti-MHC class II mAb; (b) inhibition by anti-CD4 mAb; and (c) H-2-restricted recognition of Ag. Results shown in Fig. 3 indicate that proliferation of PIV T cells was inhibited by anti-I-A/I-E and anti-CD4 antibodies. In addition, proliferation was unaffected by controls consisting of either an isotype-matched antibody, anti-CD8, or another antibody that binds to the cell surface of macrophages, anti-Mac-1.
Results concerning the MHC restriction of PIV T cells are presented in Table 3 . In experiment 1, PIV T cells were obtained using naive spleens from B10.BR mice. These cells were restimulated with Lm and APC consisting of irradiated SC from various H-2 congenic mice of the B10 series. APC from B10.AQR mice supported proliferation of B10.BR PIV T cells, indicating that class I loci K and D were not involved in Ag recognition. This would be anticipated given that PIV T cells are CD4 + 8-, although class I-restricted CD4 + cells have been observed (39) . Furthermore, APC from B10.D2 mice did not effectively present Ag to B10.BR PIV T cells, suggesting that class II is involved, as would be expected from Fig. 3 . Finally, APC from CBA/CaH-T6J mice did support proliferation, confirming that these PIV T cells were MHC restricted and were not being stimulated by genes outside the MHC region. This requirement for H-2-compatible APC 9oooo- 
Restimulation conditions
Leishmania major-specific CD4 + T Cells Derived In Vitro from Naive (B) OVA-specific T ceUs were generated from BALB/c mice as described in Materials and Methods. The cells were restimulated using conditions given for A: TC, 5 x 104 OVAspecific T cells; OVA, 100/~g/ml OVA. Proliferation was assessed as described in Materials and Methods. Antigenic Specificity of PIV T Cells, We next examined the antigenic specificity of PIV T cells (Fig. 4) 
PIV T Cells Exhibit I-A-restn'cted Antigen Recognition
H-2 region Proliferation
Exp. U / ml _+ SEM Figure 5 . Cytokine production of PIV T ceils. 7-d PIV T ceil blasts from C57BL/6 and BALB/c mice were isolated and restimulated with fresh syngeneic irradiated (900 rad) spleen cells and live Lra as described in Materials and Methods. Supematants were collected 24 h after restimulation and examined for cytokine activity by bioassay or ELISA as outlined in Materials and Methods.
Discussion
This report demonstrates that Lm-specific T cells can be generated in vitro from lymphoid tissues of normal mice. Importantly, we have further shown that the T cells generated in the PIV system arise from the naive CD44 l~ T cell population, indicating that genuine priming occurs. Furthermore, PIV T cells resemble conventional Lm-specific T cells in that they: (a) are CD4 + TCK o~lfl+; (b) are restricted to the I-A determinant of MHC class II; and (c) produce IL-2, IL-4, and IFN-% The in vitro priming phenomenon described here does not appear to be unique to Lm, as we have also observed in vitro blastogenic responses to L. m. amazonesis, L. tt brasiliensis, and L. donovani using culture conditions identical to those described here for Lm. Live L. donovani amastigotes can also induce the proliferation of parasite-specific T ceils if coincubated with naive murine SC (Paul Kaye, personal communication). Interestingly, in vitro stimulation of naive lymphocytes is not restricted to either T cells or to routine systems. For example, polyclonal B cell activation using normal murine splenocytes and Lra promastigote lysates has been observed (42) . In addition, cells from nonexposed human beings have been reported to respond in vitro to L. amazonesis, L. donovani, or Lm (43, 44) , to Plasmodiura fakiparura (45) , and to Trypanosoma cruzi (46) . Thus, it is possible that the ability to generate primary T and B cell blastogenic responses in vitro from naive hosts is not only a capability of Le/shmania but may well be a common property of protozoan parasites. This could account for the potent immunogenic response to many of these infections. For example, in mice it has been observed that as early as 3 d after infection with Lm, parasite-specific production of cytokines can be detected in the draining LNC (47) .
The facility with which Lm-specific T cell blasts can be obtained by primary in vitro immunization is remarkable. The blastogenic response to live parasites can occur even in the absence of specialized conditions such as oxygenated media, rocking of cultures, daily addition of nutrients (48), or even 2-ME, an important supplement for other in vitro priming systems (49) . Therefore, it would be useful to know how such a response is generated and which factors, such as cytokines, accessory cells, or antigens, may be involved. Second, the in vivo effects of those factors governing the PIV response should be examined.
Initially, we speculated that the Lm-specific T cells generated in the PIV system were responding to a parasite superantigen. Superantigens are highly immunogenic proteins produced by some pathogenic bacteria, and are capable of stimulating naive T cells in vitro by activating cells bearing certain Va regions regardless of the antigenic specificity of the TCR itself (50) . However, several observations argue against a leishmanial superantigen being responsible for the PIV response. First, PIV T cells exhibit clear I-A-restricted recognition of antigen (Table 3) . Although superantigens may prefer certain I-A types more than others, strict syngeneic requirements are not observed (51, 52) . Second, whereas the PIV T cells generated here are exclusively CD4 +, foreign superantigens generally stimulate both CD8 + and CD4 + T cells (52) . In addition, if a superantigen were responsible for the PIV response, one would expect to see a change in the proportional representation of predominant V~ regions in stimulated T cell populations as compared with naive ones. In the naive BALB/c mouse, •25% of splenic T cells express Vt~8.1, 8.2, or 8.3, and 10% express V/36, accounting for '~35% of all splenic T cells. Therefore, by examining the percentage of cells bearing Va8 or V~6 and the change in the V~8/V~6 ratio, most superantigen effects can be detected. For example, when BALB/c splenocytes are exposed in vitro to the superantigen staphylococcal enterotoxin B, which binds V~3, 7, 8.1, 8.2, 8.3, and 11 (53) , the V~8/V~6 ratio of 4-d T cell blasts increased sevenfold (53) . Similarly, when Y. enterocolitica superantigen containing lysates are used, which bind V~3, 7, 8.1, 9, and 11 (54) , the Va8/V~6 ratio decreased 40% (54) . In our PIV system, however, we find that V~ usage of 7-d PIV T cells is 25% Va8.1, 8.2, or 8.3, and 10% V~6, giving a V~8/V~6 ratio of 2.5:1, identical to that of naive BALB/c splenic T cells. Collectively, these data do not formally rule out a role for a superantigen-like molecule in our system but they do suggest that if a superantigen is acting, a novel mechanism is involved.
Given that a superantigen activity is unlikely, the mechanism(s) underlying the PIV phenomenon and the parasite antigen(s) that the PIV T cells recognize remain unknown. It has been shown, however, that in vitro infection of macrophages from both curing and noncuring mouse strains results in production of large amounts of IL-1 (55; H. R. Chakkalath and R. G. Titus, unpublished data), which could facilitate T cell priming. With regard to antigens, it has been demonstrated that live Lm can act as an adjuvant when coin-jected with peptides (56) . This effect can be mimicked by substituting for live organisms the 70-kD heat-shock protein (hsp) of M. bovis, M. tuberculosis, or the GroEL hsp of Escherichia coli (56) . Since the 70-kD hsp's are among the most conserved proteins throughout evolution (57) and are potent antigens of many pathogens, including Lm (58, 59) , it is possible that hsp's are partially responsible for stimulating the PIV response. The recognition of heat-shocked promastigote antigen by PIV T cells (Fig. 4) is consistent with this idea. Along with hsp's other proteins may be expressed during transformation from promastigote to amastigote. Given these considerations, we are currently examining the roles of IL-1, hsp, and amastigote antigens in the PIV system.
The data presented here show that both curing and noncuring mouse strains produce PIV T cell blasts (Table 2) , which secrete IL-2, IL-4, and IFN-y (Fig. 5) , upon exposure to Lm in vitro. Several studies indicate that IL-2 (60, 61), IL-4 (62), and other cytokines (63) (64) (65) can promote Leishmania survival both in vitro and in vivo. It is, therefore, conceivable that the early immune response to Leishmania could directly promote parasite survival. If an initial parasite-specific immune response benefits the parasite, inhibition of this early response might benefit the host. It is noteworthy that all treatments that enable noncuring BALB/c mice to control a primary infection (4-10) would inhibit T cell priming and expansion. Likewise, partial tolerance to Lm antigens in curing mouse strains C3H/HeN and (B6 x B10.D2)F1 also results in less severe disease (A. Shankar, unpublished data). Moreover, both irradiated and CD4 § T cell-depleted mice harbor fewer parasites than untreated controls during the early phase of infection (66, 67) . Hence, attenuating the initial immune response to Lm does appear to facilitate cure. As mentioned, the early response should, therefore, be exacerbative. In fact, we have adoptively transferred 7-d PIV T cell blasts from both BALB/c and C57BL/6 mice into naive syngeneic recipients and observed that lesion development was potentiated (data not shown). Thus, Lm can foster development of exacerbative cells shortly after infection such that its survival and replication is facilitated. This early response, though beneficial for the parasite in all mouse strains, may differentially influence the subsequent cure or noncure response observed in mice of different genotypes. Therefore, a better understanding of factors governing the PIV response and its potential effects in vivo may have implications for beneficial immunomodulation of leishmaniasis.
As mentioned, 7-d PIV T cell populations from both resistant and susceptible mice produced IL-2, IL-4, and IFN-3, (Fig. 5) . Hence, early in a PIV response, the responding cells are either Th0 cells or some mixture of Thl and Th2. This is consistent with recent data examining the early response to Lm in which both curing and noncuring mouse strains produced IL-4 and IFN-'), (47, 68) . These studies were performed with lymph node cells taken shortly after infection and stimulated in vitro. Since varying potentials for cytokine production can exist between peripheral lymph nodes and SC (69, 70) , we are currently examining LNC-derived PIV T cells for the cytokine these cells produce and the effect the cells have on infection with Lm in vivo. In addition, cytokine secretion patterns in long-term cultures of PIV T cells are being monitored to detect differentiation into Thl or Th2 phenotypes.
In experimental murine cutaneous leishmaniasis caused by Lm, a correlation exists between Thl parasite-specific T cell responses and disease resolution, and Th2 responses and disease progression (reviewed in reference 5). However, experiments involving T cell clones and lines from several different strains of mice indicate that a Thl or Th2 phenotype is not an indicator of protective or exacerbative function (13, 31, (71) (72) (73) . Attempts to more precisely identify Thl or Th2 cytokines regulating disease outcome have also yielded conflicting results. Infusing mAb to IFN-3r is detrimental while mAbs to IL-4 or IL-2 can be protective (4, 5, 11, 74) . However, injection of either IFN-3' or IL-4 has little effect on disease (4, 47, 74, 75) unless coadministered with adjuvant, in which case both are protective (47, 76) . Thus, a comple~ picture is emerging with respect to cytokines and preferential outgrowth of protective or exacerbative T cells after Lm infection of mice.
Clearly, the ability to precisely manipulate in vitro the conditions under which Lm-specific T cells first encounter antigen would facilitate the study of the complex interactions leading to outgrowth of protective or exacerbative T cells. The in vitro system involving Lm that has been developed and analyzed in this study shares many characteristics with the natural in vivo response to Lm during the early phase of infection. Therefore, this system may offer a tool to investigate factors responsible for development of various Th call subsets and protective or exacerbative T cells. For example, since cytokines have been shown to affect outgrowth of Th cell subsets (77) (78) (79) (80) (81) , exogenously added cytokines, both alone and in combination, can be included at the inception of a PIV response to determine whether this alters the nature of the responding Lm-specific T cell. In this respect, it is intriguing that the PIV T cells produce appreciable amounts of IL-4 since recent antigen-specific in vitro priming studies indicate that IL-4 is produced only when it is also present during priming (82) , suggesting that Lm may induce IL-4 production by some novel mechanism. Last, APC function can be examined. A role for B cells in the PlV system is dearly suggested by the fact that IL-4 was not produced by PIV T cells restimulated with 1,500-tad irradiated SC that are deficient in B cell antigen presentation, but was produced when 900-tad irradiated SC were used in which B cell presentation does occur. Several laboratories have, in fact, demonstrated effects of APC type on cytokine production by T cells (83) (84) (85) . We can, therefore, test various APC such as Langerhans cells, monocytes, or B cells in the PIV system to determine whether certain APC selectively activate protective or exacerbative Lm-specific T cells.
The advantage of the PIV approach is that control can be maintained over early events that shape the Lm-specific T cell response, i.e., T cell priming and outgrowth. The influence of factors such as cytokines, APC, and parasite antigens can, therefore, be precisely determined. Such an experimental approach may help unravel the mechanisms determining susceptibility and resistance in cutaneous leishmaniasis.
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